SCHEMBL13971486

SCHEMBL13971486

Cc1cnc(C)c(O)c1C(O)C(NC(C)C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14948150 0.86 — —
SCHEMBL14944841 0.82 ADRB2 (0.32) —
SCHEMBL13972053 0.80 MME (0.32) —
SCHEMBL13971705 0.69 KDM4E (0.35) —
SCHEMBL5666549 0.65 PNPO (0.38) —
SCHEMBL13957303 0.64 ADRA2C (0.48) —
SCHEMBL17385607 0.62 ADRB2 (0.57) —
SCHEMBL24253076 0.61 TP53 (0.43) —
SCHEMBL14572731 0.61 TP53 (0.43) —
SCHEMBL21844003 0.61 TP53 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000555-B2 Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus SEATTLE GENETICS, INC. (US) 2018-06-19 — — US disclosed
US-20090018086-A1 Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus SEATTLE GENETICS, INC. (US) 2009-01-15 — — US disclosed
Send feedback